Biologic Treatments For Elderly Patients With Psoriasis

Biologic Treatments For Elderly Patients With Psoriasis

Biologic Treatments For Elderly Patients With Psoriasis

J Dermatol. 2017 Sep;44(9):1020-1023. doi: 10.1111/1346-8138.13853. Epub 2017 Apr 25. Biologic treatments for elderly patients with psoriasis. Momose M(1) .
The number of elderly patients with psoriasis is increasing in Japan. However, biologic treatment is generally considered to be challenging in elderly patients, .
Biological therapy has revolutionized moderate to severe psoriasis treatment.. .. that elderly patients represent a significant subset of patients with psoriasis.
included in this issue we look at biologic treatments for elderly patients,. mild psoriasis, the risk of malignancy with systemic psoriasis treatment, serious .
treatments such as cyclosporine, infliximab and ustekinumab). PsA Q1: In. .. Elderly. The use of biologic agents in elderly patients (65 years or older) is limited.
Biologic agents that target TNF-α, IL-12/-23, and IL-17 inhibitors are highly. Management of elderly psoriasis patients with systemic medications may be .
Psoriatic arthritis, which affects 6 to 17% of patients with psoriasis according to. of and treatment patterns for psoriasis among the growing elderly population, which,. .. Factors associated with biologic use among patients receiving therapy .
Appropriate treatment for elderly patients with limited psoriasis include the. methotrexate, and biologics as the first-line systemic treatments for patients with .

Leave a Reply

Your email address will not be published. Required fields are marked *